期刊文献+

Grb2的抑制在抗肿瘤治疗中的意义

Inhibitation of Grb2 and anti-tumor therapy
原文传递
导出
摘要 生长因子受体连接蛋白-2(Grb2)是一种广泛表达的衔接蛋白,在多种肿瘤细胞中过度表达,对肿瘤的发生和发展具有重要影响,从而成为肿瘤治疗的靶向位点之一。因此,抑制Grb2在抗肿瘤治疗中具有广泛前景。 The growth factor receptor -bound protein-2 (Grb2) is an adapter protein in cells. Over expression of Grb2 is found in many kinds of tumor and plays an important role in tumor proliferation and progression. So it may he a molecular target for anti-tumor therapy.
出处 《肿瘤研究与临床》 CAS 2008年第11期790-792,共3页 Cancer Research and Clinic
基金 福建省医学创新课题资助项目(2007-CXB-1)
关键词 GRB2 肿瘤 治疗 Grb2 Neoplasms Therapy
  • 相关文献

参考文献30

  • 1Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions [J]. Chem Biol, 1995, 2(1): 53-60.
  • 2Pawson T, Saxton TM. Signaling networks-do all roads lead to the same genes[J]. Cell, 1999, 97(6): 675-678.
  • 3Lee JT Jr, McCubrey JA. The Raf/MEK/ERK signal transduetion cascade as a target for chemotherapeutic intervention in leukemia [J]. Leukemia, 2002, 16(4): 486-507.
  • 4Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more[J]. Nat Rev Mol Cell Biol, 2003, 4(12): 915-925.
  • 5Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia[J]. Leuk Lymphoma, 2003, 44(3): 411-427.
  • 6Gishizky ML, Cortez D, Pendergast AM. Mutant forms of growth factor-binding protein-2 reverse bcr-abl induced transformation [J]. Proc Natl Acad Sci USA, 1995, 92(24): 10889-10893.
  • 7Kardinal C, Konkol B, Lin H, et al. Chronic myelogenous leukemia blast cell proliferation is inhibited by peptides that disrupt Grb2-SOS complexes[J]. Blood, 2001, 98(6): 1773-1781.
  • 8Verbeek BS, ADRIAANSEN-SLOT SS, RIJKSEN G, et al. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens[J]. J Pathol, 1997, 183(2): 195-203.
  • 9Daly R J, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines [J]. Oncogene, 1994, 9 (9): 2723-2727.
  • 10Coppola D, Saunders B, Fu L, et al. The insulin-like growth factor 1 receptor induces transformation and tumorigenicity of ovarian mesothelial cells and down-regulates their Fas-receptor expression[J]. Cancer Res, 1999, 59(13): 3264-3270.

二级参考文献17

  • 1陈晶,单保恩,贺占国,董稚明,董金琢,马洪.信号转导和转录激活因子5与β-catenin在乳腺癌组织中的表达及其临床意义[J].中国癌症杂志,2006,16(2):89-92. 被引量:4
  • 2Zhang Z, Li M, Rayburn ER, Hill DL, Zhang R, Wang H. Oncogenes as novel targets for cancer therapy (part I ) : growth factors and protein tyrosine kinases[J]. Am J Pharmacogenomics, 2005, 5(3) :173 - 190.
  • 3Broxterman HI, Georgopapadakou NH. New cancer therapeutics: target-specific in, cytotoxics out [ J ]? Drug Resist Updat, 2004, 7(2) :79 -87.
  • 4Janes PW, Daly R J, deFazio A, Sutherland RL. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2 [ J ]. Oncogene, 1994, 9(12) :3601 - 3608.
  • 5Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions[J]. Chem Biol, 1995, 2(1 ) :53 -60.
  • 6Daly RJ, Binder MD, Sutherland RL. Overexpression of the Grb2 gene in human breast cancer cell lines [ J ]. Oncogene, 1994, 9(9) :2723 -2727.
  • 7Tari AM, Lopez-Berestein G. GRB2. a pivotal protein in signal transduction [ J ]. Semin Oncol, 2001, 28 (5 Suppl 16) : 142 - 147.
  • 8Hannon GJ. RNA interference[ J]. Nature, 2002, 418 ( 6894 ) : 244 - 251.
  • 9Feller SM, Tuchscherer G, Voss J. High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia[ J]. Leuk Lymphoma, 2003, 44(3) :411 -427.
  • 10Lowenstein EJ, Daly R J, Batzer AG, Li W, Margolis B, Lammers R, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling[J]. Cell, 1992, 70(3) :431 -442.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部